Evidence map›Paper›PMID 35865960›Full record

ArticleFrontiers in pharmacology2022

Total Barley Maiya Alkaloids Prevent Increased Prolactin Levels Caused by Antipsychotic Drugs and Reduce Dopamine Receptor D2

Yu-Ling Cao, Li -Zhu, Hong Zhang, Jun-Hua Meng, Hua-Jun Wu, Xiong Wang, Jin-Hu Wu, Ji-Li Zou, Mao-Sheng Fang, Jing An and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The Involvement of Prolactin in Stress-Related Disorders.International journal of environmental research and public health · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yu-Ling CaoPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Li -ZhuPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Hong ZhangPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Jun-Hua MengPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Hua-Jun WuPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Xiong WangPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Jin-Hu WuPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Ji-Li ZouPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Mao-Sheng FangDepartment of Psychiatry, Wuhan Mental Health Center, Wuhan, China.
Jing AnPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Yong-Gang ChenPharmacy Department of Wuhan University Tongren Hospital (The Third Hospital of Wuhan), Wuhan, China.
Tongren Hospital · CNWuhan Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antipsychotic drugsDNA methylationdopamine D2 receptorprolactintotal barley maiya alkaloids

Identifiers

PMID35865960
PMCPMC9294270
OpenAlexW4283813561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.